“…In summary, NMD activity is modulated in a number of different ways to affect specific physiological or pathological outcomes (Figure ). Some of the mechanisms that lead to NMD inhibition include downregulation of NMD factors by microRNAs (Jin, Zhang, Ma, & Ren, ; Karam & Wilkinson, ; Wang, Jiang, Jia, Chai, & Liang, ) or proteasomal degradation (Feng et al, ; Jagannathan et al, ), cleavage of specific NMD factors to produce dominant negative products (Popp & Maquat, ), competition between alternative decay pathways (Gong et al, ), translation inhibition (Li et al, ), and activation of signaling pathways such as p38 MAPK (Nickless et al, ). In physiological scenarios, NMD inhibition leads to the increased abundance of one or more physiological NMD targets that confer a benefit to the cell.…”